VKH
DSCI

Virtu KCG Holdings’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

Virtu KCG Holdings’s Portfolio DSCI Stock Details DSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-10,346
Closed -$74K – 4335
2015
Q2 		$74K Buy
+10,346
New +$77.8K ﹤0.01% 2997

Other funds holding DSCI

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Virtu KCG Holdings's DSCI Position: Q3 2015 in Review

Virtu KCG Holdings sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q3 2015, closing a stake of 10,346 shares — an estimated $74K sold.

Virtu KCG Holdings first reported a position in DSCI in Q2 2015 and held it in 1 quarter. The position peaked at $74K in Q2 2015. 55 funds tracked by Wall St. Rank hold DSCI as of Q3 2015.

  • Virtu KCG Holdings reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q3 2015 after selling out during the quarter.
  • Virtu KCG Holdings sold 10,346 Derma Sciences, Inc. Common Stock (DE) shares in Q3 2015, an estimated $74K.
  • Virtu KCG Holdings first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q2 2015 and held it in 1 quarter.
  • Virtu KCG Holdings's Derma Sciences, Inc. Common Stock (DE) position peaked at $74K in Q2 2015.
  • 55 funds tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q3 2015.

Based on Virtu KCG Holdings's 13F filing for Q3 2015, filed 13 Nov 2015.